文献速递新发突发、热带与寄生虫病

研究间日疟原虫感染的人体血阶段实验模型

An Experimental Human Blood-Stage Model for Studying Plasmodium malariae Infection.
PubMed 文献 · J Infect Dis · 2020-01-01

本研究开发了间日疟原虫(Plasmodium malariae)诱导血阶段疟疾(IBSM)模型,将冷冻保存的感染红细胞静脉接种至2名健康受试者,出现症状后用蒿甲醚-苯芴醇治疗。两例均出现早期疟疾症状,接种后7天检出虫血症,峰值虫密度分别为174 182和50 291 parasites/mL,一例观察到蚊媒传播,模型可用于研究该被忽视疟原虫的生物学、诊断和治疗。

要点

  • 间日疟原虫IBSM模型在2名健康受试者中成功建立
  • 接种后7天检出虫血症,峰值虫密度最高174 182 parasites/mL
  • 蒿甲醚-苯芴醇治疗后虫体清除半衰期为6.7小时

核心结论

  • 间日疟原虫IBSM模型已成功开发,可用于研究该被忽视疟原虫的生物学、诊断检测和治疗。

研究设计与样本

  • 临床试验纳入2名健康受试者,静脉接种冷冻保存的间日疟原虫感染红细胞,出现临床症状后接受蒿甲醚-苯芴醇治疗。

主要发现

  • 两名受试者均出现早期疟疾典型症状和体征,接种后7天检出虫血症。
  • 受试者1和2分别在接种后25天和21天启动抗疟治疗,峰值虫密度分别为174 182和50 291 parasites/mL。
  • 蒿甲醚-苯芴醇治疗后虫体清除半衰期为6.7小时,1名受试者观察到蚊媒传播,体内虫体转录谱和生物标志物成功分析。

临床怎么用

  • 该模型可用于评估间日疟原虫诊断检测方法和抗疟药物疗效。
  • 模型有助于研究间日疟原虫生物学特性及传播机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Plasmodium malariae is considered a minor malaria parasite, although its global disease burden is underappreciated. The aim of this study was to develop an induced blood-stage malaria (IBSM) model of P. malariae to study parasite biology, diagnostic assays, and treatment. METHODS: This clinical trial involved 2 healthy subjects who were intravenously inoculated with cryopreserved P. malariae-infected erythrocytes. Subjects were treated with artemether-lumefantrine after development of clinical symptoms. Prior to antimalarial therapy, mosquito-feeding assays were performed to investigate transmission, and blood samples were collected for rapid diagnostic testing and parasite transcription profiling. Serial blood samples were collected for biomarker analysis. RESULTS: Both subjects experienced symptoms and signs typical of early malaria. Parasitemia was detected 7 days after inoculation, and parasite concentrations increased until antimalarial treatment was initiated 25 and 21 days after inoculation for subjects 1 and 2 respectively (peak parasitemia levels, 174 182 and 50 291 parasites/mL, respectively). The parasite clearance half-life following artemether-lumefantrine treatment was 6.7 hours. Mosquito transmission was observed for 1 subject, while in vivo parasite transcription and biomarkers were successfully profiled. CONCLUSIONS: An IBSM model of P. malariae has been successfully developed and may be used to study the biology of, diagnostic testing for, and treatment of this neglected malaria species. CLINICAL TRIALS REGISTRATION: ACTRN12617000048381.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Woodford J, Collins KA, Odedra A, et al. An Experimental Human Blood-Stage Model for Studying Plasmodium malariae Infection. J Infect Dis. 2020. PMID: 30852586. doi:10.1093/infdis/jiz102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。